PPIA and HIV-1 infection: Disruption of CYPA binding either by mutation of the capsid (i.e., through a capsid P90A mutation) or through treatment with the CYPA inhibitor cyclosporin A (CsA) decreases HIV-1 infection due to TRIM5α-mediated restriction (Fig. 3c).